Wikipedia -WSS

Wikipedia

author：focus 2025-09-03 05:32:45 - browse：6

A photo of Robert Blum speaking at the STAT Summit West on May 16, 2024 — Cytokinetics CEO Robert Blum spoke last week at a talk during STAT’s Breakthrough Summit West in San Francisco. Sarah Gonzalez for STAT

Cytokinetics, a drugmaker that is expected to soon launch a promising new heart therapy called aficamten, said Wednesday that it had agreed to pay biotech firm Royalty Pharma a higher royalty on the medicine in return for up to $575 million, which will be used to fund the marketing of the drug and Cytokinetics’ ongoing research and development efforts.

Cytokinetics shares fell nearly 10% in after-hours trading after the announcement, which investors viewed as lowering the odds that the company will be purchased by a larger pharmaceutical company.

The firm also said that it would be raising $500 million through a stock sale.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： CRISPR base editing slashes cholesterol levels in monkeys

WSS

What will Novo Nordisk's VC do with its influx of cash?

STAT Summit: How researchers deal with rejection

Flu, Covid vaccination rates decline, new survey data show

How AI can help patients find reliable information about doctors

Results on Novartis prostate cancer therapy could expand its use

With Roe v Wade overturned, abortion providers work to adapt

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

Hollywood unions extend contract negotiations for actors

The United States is paying nearly triple for new Covid vaccines

Duchenne breakthrough therapy leaves behind pioneering families

Lawsuit highlights wrinkle for disputes over surprise medical bills

Medical leaders decry Supreme Court decision on affirmative action

The biotech scorecard for Q4: 16 stock

Drug repurposing or repositioning? The language matters

CDC picks Alphabet's Verily for wasterwater surveillance contract

The cancer drug shortage isn’t new — and neither are the solutions

What we owe ALS patients — and why one company fell short

entertainment

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Stop Congress from blocking public access to science

Results on Novartis prostate cancer therapy could expand its use

European officials brace for rough respiratory virus season

The biotech scorecard for Q4: 16 stock

The stability of $0 premiums in Medicare Advantage

hotspot

leisure time

entertainment

focus